Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines.
Stramsen Biotech has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in April 2025.
Stramsen Biotech's investors include The Global Emerging Markets Group.
Stramsen Biotech is headquartered in Houston, United States.
Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines.
Stramsen Biotech is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stramsen Biotech — Funding & Investors." VCBacked, April 7, 2025, https://www.vcbacked.co/company/stramsen-biotech. Accessed August 14, 2026.
VCBacked. (2025). Stramsen Biotech — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/stramsen-biotech
{{cite web |title=Stramsen Biotech — Funding & Investors |url=https://www.vcbacked.co/company/stramsen-biotech |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated